Similar articles

• p63RhoGEF: a new switch for G(q)-mediated activation of smooth muscle.

  Momotani K, Somlyo AV. Momotani K, et al. Trends Cardiovasc Med. 2012 Jul;22(5):122-7. doi: 10.1016/j.tcm.2012.07.007. Epub 2012 Aug 16. Trends Cardiovasc Med. 2012. PMID: 22902181 Free PMC article. Review.
• Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.

  Calò LA, Davis PA, Pagnin E, Dal Maso L, Maiolino G, Seccia TM, Pessina AC, Rossi GP. Calò LA, et al. J Hypertens. 2014 Feb;32(2):331-8. doi: 10.1097/HJH.0000000000000075. J Hypertens. 2014. PMID: 24356540
• The blocking of angiotensin II type 1 receptor and RhoA/Rho kinase activity in hypertensive patients: Effect of olmesartan medoxomil and implication with cardiovascular-renal remodeling.

  Ravarotto V, Pagnin E, Maiolino G, Fragasso A, Carraro G, Rossi B, Calò LA. Ravarotto V, et al. J Renin Angiotensin Aldosterone Syst. 2015 Dec;16(4):1245-50. doi: 10.1177/1470320315594324. Epub 2015 Aug 3. J Renin Angiotensin Aldosterone Syst. 2015. PMID: 26240115
• p63RhoGEF regulates auto- and paracrine signaling in cardiac fibroblasts.

  Ongherth A, Pasch S, Wuertz CM, Nowak K, Kittana N, Weis CA, Jatho A, Vettel C, Tiburcy M, Toischer K, Hasenfuss G, Zimmermann WH, Wieland T, Lutz S. Ongherth A, et al. J Mol Cell Cardiol. 2015 Nov;88:39-54. doi: 10.1016/j.yjmcc.2015.09.009. Epub 2015 Sep 21. J Mol Cell Cardiol. 2015. PMID: 26392029
• Angiotensin II and Cardiovascular-Renal Remodelling in Hypertension: Insights from a Human Model Opposite to Hypertension.

  Ravarotto V, Pagnin E, Fragasso A, Maiolino G, Calò LA. Ravarotto V, et al. High Blood Press Cardiovasc Prev. 2015 Sep;22(3):215-23. doi: 10.1007/s40292-015-0082-7. Epub 2015 Mar 11. High Blood Press Cardiovasc Prev. 2015. PMID: 25759028 Review.